Canada Life’s Vaxart VXRT Stock Holding History

Canada Life’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-34,686	Closed	-$75K	–	2387
2022 Q3	$75K	Buy	34,686 +27,004	+352%	+$93.1K	﹤0.01%	2035
2022 Q2	$26K	Buy	7,682 +657	+9%	+$2.45K	﹤0.01%	2222
2022 Q1	$37K	Buy	7,025 +613	+10%	+$3.1K	﹤0.01%	2230
2021 Q4	$40K	Buy	6,412 +579	+10%	+$3.95K	﹤0.01%	2234
2021 Q3	$47K	Hold	5,833	–	–	﹤0.01%	2254
2021 Q2	$44K	Hold	5,833	–	–	﹤0.01%	2310
2021 Q1	$35K	Hold	5,833	–	–	﹤0.01%	2408
2020 Q4	$33K	Buy	+5,833	New	+$37.1K	﹤0.01%	2424

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Canada Life's VXRT Position: Q4 2022 in Review

Canada Life sold out of Vaxart (VXRT) in Q4 2022, closing a stake of 34,686 shares — an estimated $75K sold.

Canada Life first reported a position in VXRT in Q4 2020 and held it in 8 quarters. The position peaked at $75K in Q3 2022. 132 funds tracked by Wall St. Rank hold VXRT as of Q4 2022.

Canada Life reported no remaining Vaxart position as of Q4 2022 after selling out during the quarter.
Canada Life sold 34,686 Vaxart shares in Q4 2022, an estimated $75K.
Canada Life first reported a position in Vaxart in Q4 2020 and held it in 8 quarters.
Canada Life's Vaxart position peaked at $75K in Q3 2022.
132 funds tracked by Wall St. Rank held Vaxart as of Q4 2022.

Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.